Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma - ScienceDirect
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
p53 siRNA (m), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
Knockdown of p53 using siRNA and its effect on mouse ESC proliferation.... | Download Scientific Diagram
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma: Molecular Therapy - Nucleic Acids
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome | Nature Communications
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice | Nature Communications
Inducible Gene and shRNA Expression in Resident Hematopoietic Stem Cells In Vivo - Laurenti - 2010 - STEM CELLS - Wiley Online Library
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy | Nature Communications
Down-Regulation of p53 by Double-Stranded RNA Modulates the Antiviral Response | Journal of Virology
Cancers | Free Full-Text | SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma | HTML
US8906874B2 - Bi-functional shRNA targeting Stathmin 1 and uses thereof - Google Patents
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness
Loss of TP53 mediates suppression of Macrophage Effector Function via Extracellular Vesicles and PDL1 towards Resistance against Chemoimmunotherapy in B-cell malignancies | bioRxiv
p53 siRNA (m), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma - ScienceDirect
